{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:43:00Z","timestamp":1776735780306,"version":"3.51.2"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04800-z","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:45:20Z","timestamp":1773377120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk-dependent conditional survival analysis and annual hazard rate of primary ocular adnexal lymphoma"],"prefix":"10.1007","volume":"17","author":[{"given":"Jiali","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shicheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"key":"4800_CR1","doi-asserted-by":"crossref","unstructured":"Sjo LD. Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol. 2009;87 Thesis 1:1\u201320.","DOI":"10.1111\/j.1755-3768.2008.01478.x"},{"key":"4800_CR2","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/bjophthalmol-2019-315637","volume":"105","author":"F Holm","year":"2021","unstructured":"Holm F, Mikkelsen LH, Kamper P, Rasmussen PK, Larsen TS, Sjo LD, Heegaard S. Ocular adnexal lymphoma in Denmark: a nationwide study of 387 cases from 1980 to 2017. Br J Ophthalmol. 2021;105:914\u201320.","journal-title":"Br J Ophthalmol"},{"key":"4800_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/ceo.14122","volume":"50","author":"F Peng","year":"2022","unstructured":"Peng F, Su W, Zhang A, Huo B, Song T, Wei Z, Geng Z, Wang L. Investigation of epidemiological characteristics and development of a nomogram to predict survival in primary ocular adnexal lymphoma. Clin Exp Ophthalmol. 2022;50:615\u201331.","journal-title":"Clin Exp Ophthalmol"},{"key":"4800_CR4","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1002\/cam4.5092","volume":"12","author":"Y Liang","year":"2023","unstructured":"Liang Y, Fu RY, Liu XL, Liu XD, Piao YS, Ma JM, Wang L. Long-term survival outcomes of patients with primary ocular adnexal MALT lymphoma: A large single-center cohort study. Cancer Med. 2023;12:2514\u201323.","journal-title":"Cancer Med"},{"key":"4800_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2478\/raon-2024-0048","volume":"58","author":"L Boltezar","year":"2024","unstructured":"Boltezar L, Strbac D, Pizem J, Hawlina G. Ocular adnexal lymphoma - a retrospective study and review of the literature. Radiol Oncol. 2024;58:416\u201324.","journal-title":"Radiol Oncol"},{"key":"4800_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1586\/eop.11.16","volume":"6","author":"R Moslehi","year":"2011","unstructured":"Moslehi R, Coles FB, Schymura MJ. Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin\u2019s lymphoma. Expert Rev Ophthalmol. 2011;6:175\u201380.","journal-title":"Expert Rev Ophthalmol"},{"key":"4800_CR7","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/ceo.14427","volume":"52","author":"J Zeng","year":"2024","unstructured":"Zeng J, Cao XF, Chen J, Liu ZP, Lyu J, Zhou Q. Assessment of prognostic factors in patients with primary ocular adnexal lymphoma when considering competing risk elements. Clin Exp Ophthalmol. 2024;52:991\u20131002.","journal-title":"Clin Exp Ophthalmol"},{"key":"4800_CR8","doi-asserted-by":"publisher","first-page":"106957","DOI":"10.1016\/j.ejso.2023.06.009","volume":"49","author":"X Meng","year":"2023","unstructured":"Meng X, Chang X, Qin P, Li Y, Guo Y. Risk-dependent conditional survival analysis and annual hazard rate of inflammatory breast cancer. Eur J Surg Oncol. 2023;49:106957.","journal-title":"Eur J Surg Oncol"},{"key":"4800_CR9","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1158\/1078-0432.CCR-14-2154","volume":"21","author":"S Hieke","year":"2015","unstructured":"Hieke S, Kleber M, Konig C, Engelhardt M, Schumacher M. Conditional Survival: A Useful Concept to Provide Information on How Prognosis Evolves over Time. Clin Cancer Res. 2015;21:1530\u20136.","journal-title":"Clin Cancer Res"},{"key":"4800_CR10","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/1078-0432.CCR-13-2125","volume":"20","author":"KR Hess","year":"2014","unstructured":"Hess KR, Levin VA. Getting more out of survival data by using the hazard function. Clin Cancer Res. 2014;20:1404\u20139.","journal-title":"Clin Cancer Res"},{"key":"4800_CR11","doi-asserted-by":"publisher","first-page":"e190194","DOI":"10.1001\/jamanetworkopen.2019.0194","volume":"2","author":"X Liu","year":"2019","unstructured":"Liu X, Wu T, Zhu SY, Shi M, Su H, Wang Y, He X, Xu LM, Yuan ZY, Zhang LL, et al. Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer\/T-Cell Lymphoma. JAMA Netw Open. 2019;2:e190194.","journal-title":"JAMA Netw Open"},{"key":"4800_CR12","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173\u2013180.","journal-title":"Lancet Oncol"},{"key":"4800_CR13","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","volume":"26","author":"A Iasonos","year":"2008","unstructured":"Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26:1364\u201370.","journal-title":"J Clin Oncol"},{"key":"4800_CR14","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1002\/cncr.28273","volume":"119","author":"EC Zabor","year":"2013","unstructured":"Zabor EC, Gonen M, Chapman PB, Panageas KS. Dynamic prognostication using conditional survival estimates. Cancer. 2013;119:3589\u201392.","journal-title":"Cancer"},{"key":"4800_CR15","doi-asserted-by":"publisher","first-page":"1119105","DOI":"10.3389\/fendo.2023.1119105","volume":"14","author":"X Meng","year":"2023","unstructured":"Meng X, Cai Y, Chang X, Guo Y. A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer. Front Endocrinol (Lausanne). 2023;14:1119105.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4800_CR16","doi-asserted-by":"publisher","first-page":"1049531","DOI":"10.3389\/fonc.2022.1049531","volume":"12","author":"X Meng","year":"2022","unstructured":"Meng X, Jiang Y, Chang X, Zhang Y, Guo Y. Conditional survival analysis and real-time prognosis prediction for cervical cancer patients below the age of 65 years. Front Oncol. 2022;12:1049531.","journal-title":"Front Oncol"},{"key":"4800_CR17","doi-asserted-by":"publisher","first-page":"e2312022","DOI":"10.1001\/jamanetworkopen.2023.12022","volume":"6","author":"D Tian","year":"2023","unstructured":"Tian D, Yan HJ, Huang H, Zuo YJ, Liu MZ, Zhao J, Wu B, Shi LZ, Chen JY. Machine Learning-Based Prognostic Model for Patients After Lung Transplantation. JAMA Netw Open. 2023;6:e2312022.","journal-title":"JAMA Netw Open"},{"key":"4800_CR18","doi-asserted-by":"crossref","unstructured":"Lin J, Yin M, Liu L, Gao J, Yu C, Liu X, Xu C, Zhu J. The development of a prediction model based on random survival forest for the postoperative prognosis of pancreatic cancer: a SEER-based study. Cancers (Basel). 2022;14(19):4667.","DOI":"10.3390\/cancers14194667"},{"key":"4800_CR19","doi-asserted-by":"publisher","first-page":"864","DOI":"10.21037\/tcr-23-1556","volume":"13","author":"Z Chen","year":"2024","unstructured":"Chen Z, Ye L, Li X. Construction and validation of a novel web-based nomogram for primary ocular adnexal lymphoma: a real-world analysis based on the Surveillance, Epidemiology, and End Results database. Transl Cancer Res. 2024;13:864\u201378.","journal-title":"Transl Cancer Res"},{"key":"4800_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ophtha.2017.05.037","volume":"125","author":"MT Yen","year":"2018","unstructured":"Yen MT, Bilyk JR, Wladis EJ, Bradley EA, Mawn LA. Treatments for Ocular Adnexal Lymphoma: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018;125:127\u201336.","journal-title":"Ophthalmology"},{"key":"4800_CR21","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","volume":"31","author":"JA Ferry","year":"2007","unstructured":"Ferry JA, Fung CY, Zukerberg L, Lucarelli MJ, Hasserjian RP, Preffer FI, Harris NL. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007;31:170\u201384.","journal-title":"Am J Surg Pathol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04800-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04800-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04800-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:29:11Z","timestamp":1776734951000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04800-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4800"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04800-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"18 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"606"}}